Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies
Open Access

Pharmacokinetics and Pharmacodynamics of Glucarpidase Rescue Treatment After High-dose Methotrexate Therapy Based on Modeling and Simulation

TOSHIMI KIMURA, YUTAKA FUKAYA, YUKIHIRO HAMADA, KENICHI YOSHIMURA and HIROSHI KAWAMOTO
Anticancer Research May 2023, 43 (5) 1919-1924; DOI: https://doi.org/10.21873/anticanres.16351
TOSHIMI KIMURA
1Department of Pharmacy, Juntendo University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTAKA FUKAYA
2Department of Pharmacy, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fukaya.yutaka{at}twmu.ac.jp
YUKIHIRO HAMADA
2Department of Pharmacy, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENICHI YOSHIMURA
3Center for Integrated Medical Research, Hiroshima University Hospital, Hiroshima, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI KAWAMOTO
4Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 5 1919-1924
DOI 
https://doi.org/10.21873/anticanres.16351
PMID 
37097666

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 27, 2023
  • Revision received March 12, 2023
  • Accepted March 15, 2023
  • Published online April 25, 2023.

Copyright & License 
Copyright © 2023 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

  1. TOSHIMI KIMURA1,
  2. YUTAKA FUKAYA2⇑,
  3. YUKIHIRO HAMADA2,
  4. KENICHI YOSHIMURA3 and
  5. HIROSHI KAWAMOTO4
  1. 1Department of Pharmacy, Juntendo University Hospital, Tokyo, Japan;
  2. 2Department of Pharmacy, Tokyo Women’s Medical University Hospital, Tokyo, Japan;
  3. 3Center for Integrated Medical Research, Hiroshima University Hospital, Hiroshima, Japan;
  4. 4Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan
  1. Correspondence to: Yutaka Fukaya, Department of Pharmacy, Tokyo Women’s Medical University Hospital, 8-1 Kawada-cho, Shinjyuku-ku, Tokyo 162-8666, Japan. Tel.: +81 333538111, Fax: +81 352697385, e-mail: fukaya.yutaka{at}twmu.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 43 (5)
Anticancer Research
Vol. 43, Issue 5
May 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacokinetics and Pharmacodynamics of Glucarpidase Rescue Treatment After High-dose Methotrexate Therapy Based on Modeling and Simulation
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Pharmacokinetics and Pharmacodynamics of Glucarpidase Rescue Treatment After High-dose Methotrexate Therapy Based on Modeling and Simulation
TOSHIMI KIMURA, YUTAKA FUKAYA, YUKIHIRO HAMADA, KENICHI YOSHIMURA, HIROSHI KAWAMOTO
Anticancer Research May 2023, 43 (5) 1919-1924; DOI: 10.21873/anticanres.16351

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Pharmacokinetics and Pharmacodynamics of Glucarpidase Rescue Treatment After High-dose Methotrexate Therapy Based on Modeling and Simulation
TOSHIMI KIMURA, YUTAKA FUKAYA, YUKIHIRO HAMADA, KENICHI YOSHIMURA, HIROSHI KAWAMOTO
Anticancer Research May 2023, 43 (5) 1919-1924; DOI: 10.21873/anticanres.16351
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • CD133+ Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense
  • Iodine-Hoechst Enhances X-ray Sensitivity of Cancer Cells Under Normal and Low Oxygen Conditions
  • Exploring SLC1A5 (ASCT2), SLC7A5, and SLC3A2 (LAT1) Genetic Variants in Colorectal Cancer: Implications for Prognosis and Personalized Care
Show more Experimental Studies

Keywords

  • Glucarpidase
  • methotrexate
  • modeling and simulation
  • pharmacokinetics
  • pharmacodynamics
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire